Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:HYPRNASDAQ:ICCMNASDAQ:NEPHNYSE:VAPO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeHYPRHyperfine$0.74+1.4%$0.70$0.53▼$1.90$56.91M0.95901,773 shs206,167 shsICCMIceCure Medical$1.01-0.5%$1.05$0.48▼$1.66$56.33M0.33477,454 shs208,123 shsNEPHNephros$3.86-9.0%$2.83$1.36▼$5.00$44.94M0.9617,232 shs49,943 shsVAPOVapotherm$2.17$2.16$0.70▼$3.44$13.58M-1.11N/A51,531 shs12 Stocks Corporate Insiders are AbandoningIf a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know? MarketBeat just compiled its list of the twelve stocks that corporate insiders are abandoning. Complete the form below to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceHYPRHyperfine+1.42%+6.89%+24.03%+3.00%-11.45%ICCMIceCure Medical-0.49%+6.18%-1.94%-9.01%+35.70%NEPHNephros-8.96%-22.80%+32.19%+131.14%+86.47%VAPOVapotherm0.00%0.00%0.00%0.00%+1.88%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationHYPRHyperfine2.6071 of 5 stars3.32.00.00.02.72.50.6ICCMIceCure Medical2.6134 of 5 stars3.84.00.00.02.00.00.6NEPHNephros2.031 of 5 stars3.53.00.00.02.20.80.0VAPOVapothermN/AN/AN/AN/AN/AN/AN/AN/ACompare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceHYPRHyperfine 2.67Moderate Buy$1.0642.93% UpsideICCMIceCure Medical 3.50Strong Buy$2.50147.52% UpsideNEPHNephros 3.00Buy$5.0029.53% UpsideVAPOVapotherm 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest VAPO, HYPR, NEPH, and ICCM Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails6/3/2025HYPRHyperfineB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy5/29/2025ICCMIceCure MedicalHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$2.505/15/2025HYPRHyperfineB. RileySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$1.20 ➝ $1.005/14/2025HYPRHyperfineWells Fargo & CompanySubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetEqual Weight ➝ Equal Weight$1.29 ➝ $0.683/28/2025ICCMIceCure MedicalHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$2.50 ➝ $2.50(Data available from 6/28/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookHYPRHyperfine$12.89M4.48N/AN/A$0.67 per share1.11ICCMIceCure Medical$3.29M17.04N/AN/A$0.12 per share8.42NEPHNephros$14.16M2.89$0.02 per share211.88$0.81 per share4.77VAPOVapotherm$68.67M0.20N/AN/A($9.01) per share-0.24Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateHYPRHyperfine-$40.72M-$0.54N/AN/AN/A-343.42%-74.19%-62.40%8/6/2025 (Estimated)ICCMIceCure Medical-$15.32M-$0.28N/AN/AN/A-467.37%-182.26%-112.65%8/19/2025 (Estimated)NEPHNephros$70K$0.0755.15∞N/A5.16%9.43%7.20%8/6/2025 (Estimated)VAPOVapotherm-$58.19M-$8.51N/A∞N/A-76.74%N/A-68.08%N/ALatest VAPO, HYPR, NEPH, and ICCM EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/28/2025Q1 2025ICCMIceCure Medical-$0.08-$0.06+$0.02-$0.06$0.75 million$0.73 million5/15/2025Q1 2025NEPHNephros-$0.0050$0.0526+$0.0576$0.05$3.67 million$4.88 million5/13/2025Q1 2025HYPRHyperfine-$0.12-$0.12N/A-$0.12$2.82 million$2.14 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthHYPRHyperfineN/AN/AN/AN/AN/AICCMIceCure MedicalN/AN/AN/AN/AN/ANEPHNephrosN/AN/AN/AN/AN/AVAPOVapothermN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioHYPRHyperfineN/A6.075.48ICCMIceCure Medical0.021.891.48NEPHNephrosN/A5.924.64VAPOVapothermN/A0.250.09Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipHYPRHyperfine15.03%ICCMIceCure Medical0.62%NEPHNephros41.10%VAPOVapotherm43.08%Insider OwnershipCompanyInsider OwnershipHYPRHyperfine30.98%ICCMIceCure Medical2.44%NEPHNephros6.70%VAPOVapotherm15.80%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableHYPRHyperfine19077.83 million53.72 millionOptionableICCMIceCure Medical6055.50 million54.15 millionNot OptionableNEPHNephros3010.60 million9.89 millionNot OptionableVAPOVapotherm2906.26 million5.27 millionNo DataVAPO, HYPR, NEPH, and ICCM HeadlinesRecent News About These CompaniesNew Study Confirms Vapotherm's Unicorn™ Cannula Provides Comparable Efficacy at Lower Flow RatesMay 20, 2025 | finance.yahoo.comGlobal High-Flow Oxygen Therapy Devices Market Set to Reach USD 1,567.2 Million by 2033 Amid Rising Demand for Respiratory Care Solutions | FMIOctober 25, 2024 | fmiblog.comFGlobal Active Humidifier Devices Market Projects Modest Decline Amid Shifting Respiratory Care Landscape | FMIOctober 25, 2024 | fmiblog.comFDecline Looms Over Global High Flow Nasal Cannula Market to reach USD 1,063.0 Million by 2034: A Call for Innovation and Adaptation | FMIOctober 21, 2024 | fmiblog.comFGlobal Endobronchial Valves Market Expected to Experience Strong Growth by 2031 | Exactitude ConsultancySeptember 24, 2024 | finance.yahoo.comVapotherm, Inc.: Vapotherm Announces Closing of MergerSeptember 20, 2024 | finanznachrichten.deVapotherm Announces Closing of MergerSeptember 20, 2024 | prnewswire.comSHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VAPO, SGE, RPHM, SQSP on Behalf of ShareholdersAugust 30, 2024 | stockhouse.comVAPO Stock Earnings: Vapotherm Reported Results for Q2 2024August 13, 2024 | msn.comVapotherm Reports Second Quarter 2024 Financial ResultsAugust 12, 2024 | prnewswire.comPLPL Plandaí Biotechnology, Inc.July 28, 2024 | seekingalpha.comVA20.SG,0P0001F4D7,0 (VA20.SG)July 23, 2024 | finance.yahoo.comSHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Vapotherm, Inc. - VAPOJuly 9, 2024 | prnewswire.comSHAREHOLDER INVESTIGATION: The M&A Class Action Firm Investigates Merger of Vapotherm, Inc. – VAPOJuly 8, 2024 | globenewswire.comThe Schall Law Firm Is Performing A Scrutiny Into Vapotherm Inc And Welcomes Investors Of VAPO To EngageJuly 1, 2024 | accesswire.comAThe Schall Law Firm Is Carrying Out An Inquiry Into Vapotherm Inc And Requests Investors Of VAPO To Be Part Of ItJune 30, 2024 | accesswire.comAThe Schall Law Firm Is Undertaking An Investigation Into Vapotherm Inc And Invites Investors Of VAPO To JoinJune 29, 2024 | accesswire.comAThe Schall Law Firm Is Leading An Investigation Into Vapotherm Inc And Invites Investors Of VAPO To JoinJune 28, 2024 | accesswire.comAThe Schall Law Firm Is Conducting A Probe Into Vapotherm Inc And Encourages VAPO Investors To ParticipateJune 27, 2024 | accesswire.comAThe Schall Law Firm Is Conducting A Probe Into Vapotherm Inc And Encourages Investors Of VAPO To ParticipateJune 26, 2024 | accesswire.comANew MarketBeat Followers Over TimeMedia Sentiment Over TimeVAPO, HYPR, NEPH, and ICCM Company DescriptionsHyperfine NASDAQ:HYPR$0.74 +0.01 (+1.42%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$0.74 -0.01 (-0.76%) As of 06/27/2025 06:27 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Hyperfine, Inc., a medical device company, provides magnetic resonance imaging (MRI) products in the United States. The company offers Swoop Portable MR imaging system, which offers portable brain neuroimaging; and support and technical assistance services. It serves ICU, comprehensive, and primary stroke accredited facilities through direct sales and distributors. Hyperfine, Inc. was founded in 2014 and is based in Guilford, Connecticut.IceCure Medical NASDAQ:ICCM$1.01 -0.01 (-0.49%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$1.03 +0.02 (+1.58%) As of 06/27/2025 07:59 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.IceCure Medical Ltd, a commercial stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors. The company offers ProSense system, a single probe system for the treatment of tumors, as well as associated disposables; and IceSense3 system for ablation indications to urology, oncology, dermatology, gynecology, general surgery, thoracic surgery, and proctology. It also develops XSense system, a single probe system; and MultiSense, a multi probe system for the treatment of multiple and larger tumors. The company was incorporated in 2006 and is headquartered in Caesarea, Israel.Nephros NASDAQ:NEPH$3.86 -0.38 (-8.96%) Closing price 06/27/2025 04:00 PM EasternExtended Trading$3.86 0.00 (-0.10%) As of 06/27/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nephros, Inc., a commercial-stage company, develops and sells water solutions to the medical and commercial markets in the United States. It offers ultrafiltration products that are used in dialysis centers for the removal of biological contaminants from water and bicarbonate concentrate; and in hospitals for the prevention of infection from waterborne pathogens, such as legionella and pseudomonas, as well as in military and outdoor recreation, commercial, and other healthcare facilities. The company also manufactures and sells water filters that enhance the taste and odor of water, as well as reduce biofilm, cysts, particulates, and scale build-up in downstream equipment. It markets its products to food service, hospitality, convenience store, and health care markets, as well as medical institutions. The company was incorporated in 1997 and is headquartered in South Orange, New Jersey.Vapotherm NYSE:VAPOVapotherm, Inc., a medical technology company, focuses on the development and commercialization of proprietary high velocity therapy products used to treat patients of various ages suffering from respiratory distress in the United States and internationally. The company offers High Velocity Therapy systems, such as HVT 2.0, Precision Flow Hi-VNI, Precision Flow Plus, and Precision Flow Classic which delivers non-invasive ventilatory support to patients by providing heated, humidified, and oxygenated air at a high velocity to treat patients through a small-bore nasal interface. It also provides companion products, including Vapotherm Transfer Unit, which allows patients to be transferred between care areas within the hospital or ambulate while on therapy; Q50 compressor that provides compressed air necessary to run the precision flow systems in areas of the hospital without access to a wall gas source; aerosol aeroneb adaptor to facilitate delivery of aerosolized solutions; aerosol disposable patient circuit that is designed to streamline the provision of continuous and intermittent delivery of aerosol solutions for patients; and tracheostomy adaptors that simplifies the connection of the High Velocity Therapy systems to a tracheostomy collar used to wean patients off mechanical ventilation. In addition, the company offers ProSoft cannula to provide gentle contact with the skin; and disposable products comprising single-use disposables and nasal interfaces, as well as Oxygen Assist Module, which helps clinicians maintain oxygen levels within a target range. Vapotherm, Inc. was founded in 1993 and is headquartered in Exeter, New Hampshire. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Nike Stock: The Mother of All Comebacks Might Have Just Begun EA Just Caught a Monster Upgrade: Bullish Breakout Ahead? Addition by Subtraction: Intel’s New Strategy Energizes Investors NVIDIA’s Stock Price Hits New Highs: This Is What’s Next Micron: A Hot Buy Heats Up, Fresh All-Time Highs Are Coming Rocket Lab: Europe Comes Calling as Momentum Builds Super Micro’s Bold $2B Bond Plan Signals 35% Premium Upside QuantumScape Soars 30%: What Drove the Next-Gen EV Stock's Rally Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
